"","gene","module","V1","V3","Protein.names","Organism","Gene.Ontology..biological.process.","Gene.Ontology.IDs"
"1","FUN_002433","ME2","ntLink_8:1537514-1543906","F1LU71","Methylglutaconyl-CoA hydratase, mitochondrial (3-MG-CoA hydratase) (EC 4.2.1.18) (AU-specific RNA-binding enoyl-CoA hydratase) (AU-binding enoyl-CoA hydratase) (Itaconyl-CoA hydratase) (EC 4.2.1.56)","Rattus norvegicus (Rat)","fatty acid beta-oxidation [GO:0006635]; leucine catabolic process [GO:0006552]","GO:0003723; GO:0003730; GO:0004300; GO:0004490; GO:0005739; GO:0006552; GO:0006635; GO:0050011"
"2","FUN_004083","ME2","ntLink_8:18989336-18999141","Q9ET22","Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase)","Mus musculus (Mouse)","lysosomal protein catabolic process [GO:1905146]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]","GO:0004177; GO:0005576; GO:0005764; GO:0005794; GO:0005829; GO:0006508; GO:0008236; GO:0008239; GO:0030163; GO:0031410; GO:0031982; GO:0043231; GO:1905146"
"8","FUN_001160","ME1","ntLink_6:9221504-9231233","P97742","Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A)","Mus musculus (Mouse)","carnitine metabolic process [GO:0009437]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; lipid localization [GO:0010876]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; regulation of fatty acid oxidation [GO:0046320]; regulation of insulin secretion [GO:0050796]; regulation of lipid storage [GO:0010883]; response to alkaloid [GO:0043279]; response to antibiotic [GO:0046677]; response to ethanol [GO:0045471]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641]","GO:0001676; GO:0004095; GO:0005739; GO:0005741; GO:0005743; GO:0006006; GO:0006631; GO:0006635; GO:0006641; GO:0009410; GO:0009437; GO:0010876; GO:0010883; GO:0014070; GO:0016020; GO:0030855; GO:0031667; GO:0032000; GO:0042755; GO:0042802; GO:0043231; GO:0043279; GO:0045471; GO:0046320; GO:0046677; GO:0050796; GO:0071398; GO:0097421; GO:1904772; GO:1990698"
"13","FUN_001396","ME1","ntLink_6:11908587-11910717","O97562","Dicarboxylate carrier SLC25A8 (Mitochondrial uncoupling protein 2) (UCP 2) (Solute carrier family 25 member 8)","Sus scrofa (Pig)","adaptive thermogenesis [GO:1990845]; C4-dicarboxylate transport [GO:0015740]; cellular response to glucose stimulus [GO:0071333]; glutamine metabolic process [GO:0006541]; glycolytic process [GO:0006096]; macrophage differentiation [GO:0030225]; mitochondrial fission [GO:0000266]; mitochondrial transmembrane transport [GO:1990542]; mitochondrial transport [GO:0006839]; reactive oxygen species metabolic process [GO:0072593]; response to cold [GO:0009409]","GO:0000266; GO:0005743; GO:0006096; GO:0006541; GO:0006839; GO:0008271; GO:0009409; GO:0015078; GO:0015131; GO:0015140; GO:0015183; GO:0015297; GO:0015740; GO:0017077; GO:0022857; GO:0030225; GO:0042803; GO:0071333; GO:0072593; GO:0140787; GO:1990542; GO:1990845"
"19","FUN_007022","ME9","ptg000001l:19386902-19398415","Q8WP19","Cryptochrome-1","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein ubiquitination [GO:0031398]; regulation of circadian rhythm [GO:0042752]; regulation of DNA damage checkpoint [GO:2000001]; response to activity [GO:0014823]; response to glucagon [GO:0033762]; response to light stimulus [GO:0009416]; signal transduction in response to DNA damage [GO:0042770]","GO:0000122; GO:0000166; GO:0005634; GO:0005737; GO:0006094; GO:0007623; GO:0009416; GO:0009881; GO:0014823; GO:0031397; GO:0031398; GO:0032922; GO:0033762; GO:0042593; GO:0042752; GO:0042754; GO:0042770; GO:0043153; GO:0045721; GO:0045744; GO:0045892; GO:2000001; GO:2000323"
"22","FUN_008282","ME3","ptg000002l:9911971-9929166","Q9VCU9","Endoribonuclease Dcr-1 (Protein dicer-1) (EC 3.1.26.-)","Drosophila melanogaster (Fruit fly)","apoptotic DNA fragmentation [GO:0006309]; dendrite morphogenesis [GO:0048813]; dsRNA transport [GO:0033227]; germ-line stem cell division [GO:0042078]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; miRNA processing [GO:0035196]; mitotic cell cycle, embryonic [GO:0045448]; pole cell formation [GO:0007279]; pre-miRNA processing [GO:0031054]; response to starvation [GO:0042594]; RISC complex assembly [GO:0070922]; RNA phosphodiester bond hydrolysis [GO:0090501]; RNA-mediated post-transcriptional gene silencing [GO:0035194]; segment polarity determination [GO:0007367]; siRNA processing [GO:0030422]","GO:0003723; GO:0003727; GO:0004386; GO:0004525; GO:0004530; GO:0005524; GO:0005737; GO:0006309; GO:0007279; GO:0007294; GO:0007367; GO:0016442; GO:0016443; GO:0030422; GO:0030727; GO:0031054; GO:0033227; GO:0035194; GO:0035196; GO:0042078; GO:0042594; GO:0045448; GO:0046872; GO:0048813; GO:0070578; GO:0070883; GO:0070922; GO:0090501"
"26","FUN_008660","ME14","ptg000002l:14136576-14138681","Q5R9Y4","Ras-related protein Rab-7a (EC 3.6.5.2)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","early endosome to late endosome transport [GO:0045022]; endosome to plasma membrane protein transport [GO:0099638]; lipid catabolic process [GO:0016042]; lipophagy [GO:0061724]; phagosome acidification [GO:0090383]; phagosome-lysosome fusion [GO:0090385]","GO:0000421; GO:0003925; GO:0005525; GO:0005739; GO:0005765; GO:0005770; GO:0005811; GO:0005829; GO:0016042; GO:0030670; GO:0031902; GO:0031966; GO:0033162; GO:0045022; GO:0045335; GO:0061724; GO:0090383; GO:0090385; GO:0099638"
"27","FUN_008934","ME8","ptg000004l:622874-629747","A5D7I4","Exostosin-1 (EC 2.4.1.224) (EC 2.4.1.225) (Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Multiple exostoses protein 1 homolog)","Bos taurus (Bovine)","antigen processing and presentation [GO:0019882]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; bone resorption [GO:0045453]; canonical Wnt signaling pathway [GO:0060070]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cell adhesion mediated by integrin [GO:0033627]; cell fate commitment [GO:0045165]; cellular response to virus [GO:0098586]; chondrocyte hypertrophy [GO:0003415]; chondrocyte proliferation [GO:0035988]; chondroitin sulfate metabolic process [GO:0030204]; collagen fibril organization [GO:0030199]; cranial skeletal system development [GO:1904888]; dendrite self-avoidance [GO:0070593]; dendritic cell migration [GO:0036336]; developmental growth involved in morphogenesis [GO:0060560]; embryonic skeletal joint development [GO:0072498]; endochondral bone growth [GO:0003416]; endochondral ossification [GO:0001958]; endoderm development [GO:0007492]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fear response [GO:0042596]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fluid transport [GO:0042044]; gastrulation [GO:0007369]; gene expression [GO:0010467]; glandular epithelial cell differentiation [GO:0002067]; glomerular basement membrane development [GO:0032836]; hair follicle morphogenesis [GO:0031069]; heart contraction [GO:0060047]; heart field specification [GO:0003128]; hematopoietic stem cell differentiation [GO:0060218]; hematopoietic stem cell homeostasis [GO:0061484]; hematopoietic stem cell migration to bone marrow [GO:0097241]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; hypersensitivity [GO:0002524]; leukocyte tethering or rolling [GO:0050901]; limb joint morphogenesis [GO:0036022]; lymphocyte adhesion to endothelial cell of high endothelial venule [GO:0036339]; lymphocyte migration into lymphoid organs [GO:0097021]; mesenchymal cell differentiation involved in bone development [GO:1901706]; mesoderm development [GO:0007498]; motor behavior [GO:0061744]; multicellular organism growth [GO:0035264]; multicellular organismal water homeostasis [GO:0050891]; neural crest cell differentiation [GO:0014033]; olfactory bulb development [GO:0021772]; optic nerve development [GO:0021554]; ossification involved in bone maturation [GO:0043931]; perichondral bone morphogenesis [GO:0061974]; podocyte differentiation [GO:0072112]; protein catabolic process [GO:0030163]; protein glycosylation [GO:0006486]; protein-containing complex assembly [GO:0065003]; regulation of blood pressure [GO:0008217]; response to heparin [GO:0071503]; response to leukemia inhibitory factor [GO:1990823]; response to light intensity [GO:0009642]; sebaceous gland development [GO:0048733]; smoothened signaling pathway involved in lung development [GO:0060506]; social behavior [GO:0035176]; sodium ion homeostasis [GO:0055078]; stem cell division [GO:0017145]; stomach development [GO:0062094]; sulfation [GO:0051923]; sweat gland development [GO:0060792]; synaptic transmission, glutamatergic [GO:0035249]; tight junction organization [GO:0120193]; TNFSF11-mediated signaling pathway [GO:0071847]; vacuole organization [GO:0007033]; vasodilation [GO:0042311]; vocalization behavior [GO:0071625]; wound healing [GO:0042060]","GO:0000139; GO:0001958; GO:0001974; GO:0002067; GO:0002524; GO:0003128; GO:0003415; GO:0003416; GO:0005789; GO:0005794; GO:0006486; GO:0007033; GO:0007369; GO:0007411; GO:0007492; GO:0007498; GO:0008217; GO:0008375; GO:0008543; GO:0009642; GO:0010467; GO:0014033; GO:0015014; GO:0015020; GO:0016757; GO:0017145; GO:0019882; GO:0021554; GO:0021772; GO:0030163; GO:0030199; GO:0030204; GO:0030210; GO:0030509; GO:0031069; GO:0032836; GO:0033627; GO:0035176; GO:0035249; GO:0035264; GO:0035988; GO:0036022; GO:0036336; GO:0036339; GO:0042044; GO:0042060; GO:0042311; GO:0042596; GO:0042803; GO:0043931; GO:0045165; GO:0045202; GO:0045453; GO:0046872; GO:0046982; GO:0048733; GO:0050508; GO:0050509; GO:0050891; GO:0050901; GO:0051923; GO:0055078; GO:0060047; GO:0060070; GO:0060218; GO:0060351; GO:0060441; GO:0060506; GO:0060560; GO:0060792; GO:0061484; GO:0061744; GO:0061974; GO:0062094; GO:0065003; GO:0070593; GO:0071503; GO:0071625; GO:0071711; GO:0071847; GO:0072112; GO:0072498; GO:0097021; GO:0097241; GO:0098586; GO:0120193; GO:1901706; GO:1904888; GO:1990823"
"31","FUN_011908","ME14","ptg000008l:2748000-2770398","Q5R4G2","Platelet-activating factor acetylhydrolase IB subunit alpha2 (EC 3.1.1.47) (PAF acetylhydrolase 30 kDa subunit) (PAF-AH 30 kDa subunit) (PAF-AH subunit beta) (PAFAH subunit beta)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","lipid catabolic process [GO:0016042]; positive regulation of macroautophagy [GO:0016239]; spermatogenesis [GO:0007283]","GO:0001650; GO:0003847; GO:0005829; GO:0005886; GO:0007283; GO:0008247; GO:0016042; GO:0016239; GO:0042803; GO:0046982"
"39","FUN_012474","ME1","ptg000008l:9228493-9235608","Q9XTR8","Lipase ZK262.3 (EC 3.1.1.-)","Caenorhabditis elegans","lipid catabolic process [GO:0016042]","GO:0005576; GO:0016042; GO:0016787"
"44","FUN_015434","ME14","ptg000009l:10125666-10128350","P53448","Fructose-bisphosphate aldolase C (EC 4.1.2.13) (Brain-type aldolase)","Carassius auratus (Goldfish)","fructose 1,6-bisphosphate metabolic process [GO:0030388]; glycolytic process [GO:0006096]","GO:0004332; GO:0006096; GO:0030388"
"50","FUN_023367","ME1","ptg000017l:6723553-6730063","P17712","Hexokinase-4 (HK4) (EC 2.7.1.1) (Glucokinase) (Hexokinase type IV) (HK IV) (Hexokinase-D)","Rattus norvegicus (Rat)","calcium ion import [GO:0070509]; carbohydrate phosphorylation [GO:0046835]; cellular glucose homeostasis [GO:0001678]; cellular response to glucose starvation [GO:0042149]; cellular response to insulin stimulus [GO:0032869]; cellular response to leptin stimulus [GO:0044320]; detection of glucose [GO:0051594]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycolytic process [GO:0006096]; lipid homeostasis [GO:0055088]; mannose metabolic process [GO:0006013]; NADP metabolic process [GO:0006739]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gluconeogenesis [GO:0045721]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of glycolytic process [GO:0045821]; positive regulation of insulin secretion [GO:0032024]; positive regulation of phosphorylation [GO:0042327]; regulation of insulin secretion [GO:0050796]; regulation of potassium ion transport [GO:0043266]; response to glucose [GO:0009749]; second-messenger-mediated signaling [GO:0019932]","GO:0000287; GO:0001678; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005938; GO:0005978; GO:0006002; GO:0006003; GO:0006006; GO:0006013; GO:0006096; GO:0006739; GO:0007204; GO:0008865; GO:0009749; GO:0019158; GO:0019903; GO:0019932; GO:0030141; GO:0032024; GO:0032811; GO:0032869; GO:0042149; GO:0042327; GO:0042593; GO:0043266; GO:0043531; GO:0044320; GO:0045180; GO:0045721; GO:0045725; GO:0045821; GO:0046835; GO:0050796; GO:0051156; GO:0051594; GO:0055088; GO:0070509"
"52","FUN_023596","ME2","ptg000017l:9699993-9702655","Q9Y5Y6","Suppressor of tumorigenicity 14 protein (EC 3.4.21.109) (Matriptase) (Membrane-type serine protease 1) (MT-SP1) (Prostamin) (Serine protease 14) (Serine protease TADG-15) (Tumor-associated differentially-expressed gene 15 protein)","Homo sapiens (Human)","epithelial cell morphogenesis involved in placental branching [GO:0060672]; keratinocyte differentiation [GO:0030216]; neural tube closure [GO:0001843]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]","GO:0001843; GO:0004252; GO:0005615; GO:0005886; GO:0006508; GO:0008236; GO:0009897; GO:0016323; GO:0030163; GO:0030216; GO:0060672"
"54","FUN_025232","ME2","ptg000019l:257406-264111","P55070","Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12)","Lactarius deterrimus (False saffron milkcap)","glycolytic process [GO:0006096]","GO:0004365; GO:0005737; GO:0006096; GO:0051287"
"58","FUN_026128","ME41","ptg000020l:4918603-4924154","P42574","Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]","Homo sapiens (Human)","anterior neural tube closure [GO:0061713]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; axonal fasciculation [GO:0007413]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to staurosporine [GO:0072734]; epithelial cell apoptotic process [GO:1904019]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway [GO:0097191]; fibroblast apoptotic process [GO:0044346]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to osmotic stress [GO:0008627]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; leukocyte apoptotic process [GO:0071887]; luteolysis [GO:0001554]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of B cell proliferation [GO:0030889]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; platelet formation [GO:0030220]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; protein catabolic process [GO:0030163]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of macroautophagy [GO:0016241]; regulation of protein stability [GO:0031647]; response to amino acid [GO:0043200]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]; response to X-ray [GO:0010165]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; striated muscle cell differentiation [GO:0051146]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060]","GO:0001554; GO:0001666; GO:0001782; GO:0002020; GO:0004190; GO:0004197; GO:0004861; GO:0005123; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006974; GO:0007413; GO:0007507; GO:0007605; GO:0007611; GO:0008233; GO:0008303; GO:0008627; GO:0009410; GO:0009411; GO:0009749; GO:0010165; GO:0016005; GO:0016241; GO:0016485; GO:0021766; GO:0030163; GO:0030182; GO:0030216; GO:0030218; GO:0030220; GO:0030889; GO:0031264; GO:0031647; GO:0032025; GO:0032355; GO:0032496; GO:0034349; GO:0034612; GO:0035094; GO:0042060; GO:0042542; GO:0043025; GO:0043029; GO:0043065; GO:0043200; GO:0043525; GO:0044346; GO:0044877; GO:0045121; GO:0045165; GO:0046007; GO:0046677; GO:0048011; GO:0051146; GO:0051384; GO:0051402; GO:0061713; GO:0071887; GO:0072734; GO:0097153; GO:0097190; GO:0097191; GO:0097193; GO:0097194; GO:0097199; GO:0097200; GO:1902004; GO:1902512; GO:1904019"
"59","FUN_027948","ME32","ptg000021l:13714157-13715126","Q63HM9","PI-PLC X domain-containing protein 3","Homo sapiens (Human)","lipid catabolic process [GO:0016042]; signal transduction [GO:0007165]","GO:0005737; GO:0007165; GO:0008081; GO:0016042; GO:0045202"
"61","FUN_028200","ME2","ptg000021l:16810807-16815447","Q4R7L3","26S proteasome regulatory subunit 6B (26S proteasome AAA-ATPase subunit RPT3) (Proteasome 26S subunit ATPase 4)","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","protein catabolic process [GO:0030163]","GO:0005524; GO:0005654; GO:0005829; GO:0016887; GO:0022624; GO:0030163; GO:0036402"
"67","FUN_032220","ME1","ptg000023l:29856466-29862755","Q19749","Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial (EC 2.3.1.12) (Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex) (Pyruvate dehydrogenase complex component E2) (PDC-E2) (PDCE2)","Caenorhabditis elegans","acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]","GO:0004742; GO:0005967; GO:0006086; GO:0006096"
"68","FUN_033720","ME4","ptg000024l:673513-676224","Q8VDL4","ADP-dependent glucokinase (ADP-GK) (ADPGK) (EC 2.7.1.147)","Mus musculus (Mouse)","carbohydrate metabolic process [GO:0005975]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]","GO:0005576; GO:0005783; GO:0005975; GO:0006006; GO:0006096; GO:0043843; GO:0046872"
"74","FUN_035467","ME14","ptg000025l:7690136-7695911","Q16822","Phosphoenolpyruvate carboxykinase [GTP], mitochondrial (PEPCK-M) (EC 4.1.1.32)","Homo sapiens (Human)","cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; NADH oxidation [GO:0006116]; oxaloacetate metabolic process [GO:0006107]; positive regulation of insulin secretion [GO:0032024]; propionate catabolic process [GO:0019543]; response to lipid [GO:0033993]; response to lipopolysaccharide [GO:0032496]; response to starvation [GO:0042594]","GO:0004611; GO:0004613; GO:0005525; GO:0005739; GO:0005759; GO:0005829; GO:0006094; GO:0006107; GO:0006116; GO:0019543; GO:0030145; GO:0032024; GO:0032496; GO:0032869; GO:0033993; GO:0042594; GO:0046327; GO:0070365; GO:0071333; GO:0071356; GO:0071549"
"75","FUN_035468","ME8","ptg000025l:7702781-7707570","Q8BH04","Phosphoenolpyruvate carboxykinase [GTP], mitochondrial (PEPCK-M) (EC 4.1.1.32)","Mus musculus (Mouse)","cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; NADH oxidation [GO:0006116]; oxaloacetate metabolic process [GO:0006107]; positive regulation of insulin secretion [GO:0032024]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; response to lipid [GO:0033993]; response to starvation [GO:0042594]","GO:0004611; GO:0004613; GO:0005525; GO:0005739; GO:0005759; GO:0005829; GO:0006090; GO:0006094; GO:0006107; GO:0006116; GO:0019543; GO:0030145; GO:0032024; GO:0032869; GO:0033993; GO:0042594; GO:0046327; GO:0070365; GO:0071333; GO:0071549"
"79","FUN_037573","ME2","ptg000026l:11925692-11934635","O42586","26S proteasome regulatory subunit 6A-B (26S proteasome AAA-ATPase subunit RPT5-B) (Proteasome 26S subunit ATPase 3-B) (Tat-binding protein 10) (TBP-10)","Xenopus laevis (African clawed frog)","protein catabolic process [GO:0030163]","GO:0005524; GO:0005634; GO:0005737; GO:0016887; GO:0022624; GO:0030163; GO:0036402"
"83","FUN_039293","ME2","ptg000028l:389925-395432","P55070","Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12)","Lactarius deterrimus (False saffron milkcap)","glycolytic process [GO:0006096]","GO:0004365; GO:0005737; GO:0006096; GO:0051287"
"88","FUN_040784","ME13","ptg000031l:12653616-12663860","O65201","Acyl-coenzyme A oxidase 2, peroxisomal (AOX 2) (EC 1.3.3.6) (Long-chain acyl-CoA oxidase) (AtCX2)","Arabidopsis thaliana (Mouse-ear cress)","fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088]; long-chain fatty acid metabolic process [GO:0001676]","GO:0001676; GO:0003997; GO:0005504; GO:0005777; GO:0006635; GO:0033540; GO:0050660; GO:0055088; GO:0071949"
"89","FUN_041710","ME2","ptg000035l:6737981-6752397","Q5LUF3","Propionyl-CoA carboxylase alpha chain (EC 6.4.1.3)","Ruegeria pomeroyi (strain ATCC 700808 / DSM 15171 / DSS-3) (Silicibacter pomeroyi)","lipid catabolic process [GO:0016042]","GO:0004658; GO:0005524; GO:0016042; GO:0046872"
"90","FUN_041721","ME5","ptg000035l:6790698-6792011","Q5R4G2","Platelet-activating factor acetylhydrolase IB subunit alpha2 (EC 3.1.1.47) (PAF acetylhydrolase 30 kDa subunit) (PAF-AH 30 kDa subunit) (PAF-AH subunit beta) (PAFAH subunit beta)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","lipid catabolic process [GO:0016042]; positive regulation of macroautophagy [GO:0016239]; spermatogenesis [GO:0007283]","GO:0001650; GO:0003847; GO:0005829; GO:0005886; GO:0007283; GO:0008247; GO:0016042; GO:0016239; GO:0042803; GO:0046982"
"93","FUN_042950","ME0","ptg000047l:2301377-2311682","Q12933","TNF receptor-associated factor 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF2) (RING-type E3 ubiquitin transferase TRAF2) (Tumor necrosis factor type 2 receptor-associated protein 3)","Homo sapiens (Human)","activation of NF-kappaB-inducing kinase activity [GO:0007250]; cellular response to nitric oxide [GO:0071732]; interleukin-17-mediated signaling pathway [GO:0097400]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mRNA stabilization [GO:0048255]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron death [GO:1901215]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein K63-linked ubiquitination [GO:0070534]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; regulation of protein-containing complex assembly [GO:0043254]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0000151; GO:0002637; GO:0002726; GO:0002947; GO:0004842; GO:0005164; GO:0005174; GO:0005654; GO:0005829; GO:0005938; GO:0007165; GO:0007250; GO:0008270; GO:0009898; GO:0012506; GO:0019899; GO:0019901; GO:0019903; GO:0023019; GO:0030163; GO:0030674; GO:0031435; GO:0031625; GO:0031996; GO:0032743; GO:0033209; GO:0034351; GO:0034976; GO:0035631; GO:0042802; GO:0042981; GO:0043120; GO:0043122; GO:0043123; GO:0043254; GO:0043507; GO:0044877; GO:0045121; GO:0046330; GO:0046625; GO:0048255; GO:0051091; GO:0051092; GO:0051865; GO:0065003; GO:0070059; GO:0070534; GO:0071732; GO:0097057; GO:0097300; GO:0097400; GO:1901215; GO:1903265; GO:1903721; GO:1990604; GO:2001238"
"97","FUN_042982","ME12","ptg000047l:2690313-2698318","Q8BS35","Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195)","Mus musculus (Mouse)","ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]","GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0008610; GO:0046485; GO:0050479"
